170 related articles for article (PubMed ID: 8636012)
1. Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens.
Hattori Y; Tashiro H; Kawamoto T; Kodama Y
Jpn J Cancer Res; 1995 Dec; 86(12):1210-5. PubMed ID: 8636012
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.
Aoki K; Misumi J; Kimura T; Zhao W; Xie T
J Epidemiol; 1997 Sep; 7(3):143-51. PubMed ID: 9337512
[TBL] [Abstract][Full Text] [Related]
3. Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults.
Kikuchi S; Wada O; Miki K; Nakajima T; Nishi T; Kobayashi O; Inaba Y
Cancer; 1994 Jun; 73(11):2695-702. PubMed ID: 8194008
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein.
Chung HW; Kim JW; Lee JH; Song SY; Chung JB; Kwon OH; Lim JB
J Clin Gastroenterol; 2009 Jan; 43(1):19-26. PubMed ID: 18648315
[TBL] [Abstract][Full Text] [Related]
5. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
[TBL] [Abstract][Full Text] [Related]
7. The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer.
Juan Cai W; Yin L; Kang Q; Chen Zeng Z; Liang Wang S; Cheng J
Sci Rep; 2017 Mar; 7():43536. PubMed ID: 28251999
[TBL] [Abstract][Full Text] [Related]
8. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
9. A minute gastric cancer detected by a new screening method using serum pepsinogen I and II.
Yahagi N; Miki K; Ichinose M; Kakei N; Matsushima M; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K
Adv Exp Med Biol; 1995; 362():145-8. PubMed ID: 8540313
[No Abstract] [Full Text] [Related]
10. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.
Miki K; Ichinose M; Ishikawa KB; Yahagi N; Matsushima M; Kakei N; Tsukada S; Kido M; Ishihama S; Shimizu Y
Jpn J Cancer Res; 1993 Oct; 84(10):1086-90. PubMed ID: 8226283
[TBL] [Abstract][Full Text] [Related]
11. Serum pepsinogens I and II and stomach cancer.
Stemmermann GN; Samloff IM; Nomura AM; Heilbrun LK
Clin Chim Acta; 1987 Mar; 163(2):191-8. PubMed ID: 3568423
[TBL] [Abstract][Full Text] [Related]
12. Western long-term accuracy of serum pepsinogen-based gastric cancer screening.
Castro C; Dinis-Ribeiro M; Rodrigues ANG; Calheiros T; Santos J; Pereira P; Ramos M; Cunha H; Andrade M; Costa A; Sá L; Antunes L; Bento MJ; Lomba-Viana R
Eur J Gastroenterol Hepatol; 2018 Mar; 30(3):274-277. PubMed ID: 29215432
[TBL] [Abstract][Full Text] [Related]
13. Serum pepsinogens as a screening test of extensive chronic gastritis.
Miki K; Ichinose M; Shimizu A; Huang SC; Oka H; Furihata C; Matsushima T; Takahashi K
Gastroenterol Jpn; 1987 Apr; 22(2):133-41. PubMed ID: 3596151
[TBL] [Abstract][Full Text] [Related]
14. Using serum pepsinogens wisely in a clinical practice.
Miki K; Urita Y
J Dig Dis; 2007 Feb; 8(1):8-14. PubMed ID: 17261129
[TBL] [Abstract][Full Text] [Related]
15. Validation of the pepsinogen test method for gastric cancer screening using a follow-up study.
Mizuno S; Kobayashi M; Tomita S; Miki I; Masuda A; Onoyama M; Habu Y; Inokuchi H; Watanabe Y
Gastric Cancer; 2009; 12(3):158-63. PubMed ID: 19890696
[TBL] [Abstract][Full Text] [Related]
16. Pepsinogen test for the evaluation of precancerous changes in gastric mucosa: a population-based study.
Sjomina O; Pavlova J; Daugule I; Janovic P; Kikuste I; Vanags A; Tolmanis I; Rudzite D; Polaka I; Kojalo I; Liepniece-Karele I; Isajevs S; Santare D; Pirags V; Pahomova J; Dzerve V; Tzivian L; Erglis A; Leja M
J Gastrointestin Liver Dis; 2018 Mar; 27(1):11-17. PubMed ID: 29557410
[TBL] [Abstract][Full Text] [Related]
17. Serum pepsinogen in screening for gastric cancer.
Kodoi A; Yoshihara M; Sumii K; Haruma K; Kajiyama G
J Gastroenterol; 1995 Aug; 30(4):452-60. PubMed ID: 7550854
[TBL] [Abstract][Full Text] [Related]
18. [Pepsinogen].
Miki K
Nihon Rinsho; 1995 May; 53(5):1198-202. PubMed ID: 7602778
[TBL] [Abstract][Full Text] [Related]
19. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Yanaoka K; Oka M; Mukoubayashi C; Yoshimura N; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Ohata H; Fujishiro M; Takeshita T; Mohara O; Ichinose M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):838-45. PubMed ID: 18398025
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of serum pepsinogen I and II of patients with gastric cancer].
Kimura Y; Fujii T; Hamamoto K; Miyagawa N; Tsuda K; Tanada S; Iio A
Kaku Igaku; 1989 Sep; 26(9):1127-33. PubMed ID: 2810910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]